Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN)
Historical Holders from Q1 2023 to Q3 2025
-
Type / Class
-
Equity / Common Stock, no par value
-
Symbol
-
CYCN on Nasdaq
-
Shares outstanding
-
3,367,000
-
Price per share
-
$1.70
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
258,836
-
Total reported value
-
$595,353
-
% of total 13F portfolios
-
0%
-
Share change
-
-103,980
-
Value change
-
-$333,887
-
Number of holders
-
17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
Hecht Peter M
|
28%
|
|
$3,803,918
|
|
1,028,086
|
|
Peter M. Hecht
|
25 Mar 2025
|
|
J. WOOD CAPITAL ADVISORS LLC
|
5.4%
|
|
$496,363
|
|
181,818
|
|
J. Wood Capital Advisors LLC
|
25 Mar 2025
|
|
TYNDALL CAPITAL PARTNERS L P
|
4.8%
|
-6%
|
$487,287
|
-$30,113
|
155,187
|
-5.8%
|
Tyndall Capital Partners, L.P.
|
30 Jun 2025
|
|
American Endowment Foundation
|
4.9%
|
|
$492,196
|
|
133,026
|
|
American Endowment Foundation
|
31 Dec 2024
|
|
FMR LLC
|
0.2%
|
|
$17,538
|
|
4,740
|
|
FMR LLC
|
31 Dec 2024
|
As of 30 Sep 2025,
Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) has
17
institutional shareholders
filing 13F forms.
They hold
258,836 shares.
of 3,367,000
outstanding shares (7.7%)
.
Institutional Holders of Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
258,836
|
$595,353
|
-$333,887
|
|
|
$2.30
|
17
|
|
2025 Q2
|
362,816
|
$1,055,824
|
-$30,767
|
|
|
$2.91
|
17
|
|
2025 Q1
|
373,392
|
$931,696
|
-$29,342
|
|
|
$2.50
|
18
|
|
2024 Q4
|
382,073
|
$1,230,314
|
-$1,793,165
|
|
|
$3.22
|
19
|
|
2024 Q3
|
1,042,639
|
$2,696,608
|
-$289,148
|
|
|
$2.59
|
15
|
|
2024 Q2
|
1,051,710
|
$2,411,691
|
-$42,676
|
|
|
$2.30
|
17
|
|
2024 Q1
|
1,070,254
|
$3,424,719
|
+$2,411
|
|
$0
|
$3.20
|
15
|
|
2023 Q4
|
1,069,490
|
$3,583,217
|
-$8,652
|
|
$286,760
|
$3.35
|
15
|
|
2023 Q3
|
1,072,275
|
$3,658,805
|
+$244,093
|
|
$340,288
|
$3.42
|
17
|
|
2023 Q2
|
995,440
|
$4,096,493
|
+$4,096,489
|
|
$499,216
|
$4.12
|
17
|
|
2023 Q1
|
10
|
$4
|
+$4
|
|
|
$0.40
|
1
|